Ligand Pharmaceuticals Reports Strong Fourth Quarter Earnings and Sales Performance
Ligand Pharmaceuticals (NASDAQ: LGND) announced their fourth-quarter earnings on February 27, 2024, with earnings of $1.38 per share, which exceeded ...
Ligand Pharmaceuticals (NASDAQ: LGND) announced their fourth-quarter earnings on February 27, 2024, with earnings of $1.38 per share, which exceeded ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.